期刊文献+

卵巢Sertoli-Leydig细胞瘤临床病理分析 被引量:4

Clinicopathological Analysis of Sertoli-Leydig Cell Tumor of Ovary
下载PDF
导出
摘要 目的探讨卵巢Sertoli-Leydig细胞瘤的临床病理学特征。方法对卵巢Sertoli-Leydig细胞瘤进行临床资料、组织病理和免疫表型观察,并复习相关文献。结果卵巢Sertoli-Leydig细胞瘤是一种非常少见的性索-间质肿瘤,特征是出现不同比例和不同分化水平的Sertoli细胞、Leydig细胞和(或)纤维母细胞。免疫组化:Inhibin(+)、VIM(+)。结论卵巢Sertoli-Leydig细胞瘤是一种形态学表现多样的少见肿瘤,诊断主要依据病理形态学特征,免疫组化对诊断可起一定的辅助作用。 Objective To explore the clinicopathological features of Sertoli-Leydig cell tumor of ovary. Methods The clinical data,histopathological examination and immunohistochemical examination of Sertoli-Leydig cell tumor of ovary were observed,and the relevant literatures were reviewed. Results Sertoli-Leydig cell tumor of ovary was a kind of rare sex cord-stromal tumor. The sertoil cells,leydig cells and(or)fibroblast demonstrate were observed in the various sizes and levels. Immunohistochemical features:Inhibin( + ),VIM( + ). Conclusion Sertoli-Leydig cell tumor of ovary is a kind of rare tumor. The diagnosis mostly depends on the clinic symptoms and histological fea-tures,the immunohistochemistry can be helpful for the diagnosis.
出处 《肿瘤基础与临床》 2014年第2期145-146,共2页 journal of basic and clinical oncology
关键词 卵巢肿瘤 Sertoli-Leydig 细胞瘤 免疫组化 ovarian tumor Sertoli-Leydig cell tumor immunohistochemistry
  • 相关文献

参考文献4

二级参考文献24

  • 1Tavassoli FA, Devilee P. World Health Organization classification of tumours. Pathology and genetics tumours of the breast and female genital organs. Lyon : IARC ,2003.
  • 2Choong CS, Fuller PJ, Chu S,et al. Sertoli-Leydig cell tumor of the ovary, a rare cause of precocious puberty in a 12-month-old infant. J Clin Endocrinol Metab ,2002,87 (1) :49-56.
  • 3Young RH, Scully RE. Ovarian Sertoli-Leydig cell tumors. A clinicopathological analysis of 207 cases. Am J Surg Pathol,1985,9(8) :543-569.
  • 4Yao DX,Soslow RA,Hedvat CV, et al. Melan-A ( A103 ) and inhibin expression in ovarian neoplasms. Appl Immunohistochem Mol Morphol, 2003,11 (3) :244-249.
  • 5Movahedi-Lankarani S, Kurman RJ. Calretinin, a more sensitive but less specific marker than alpha-inhibin for ovarian sex cord-stromal neoplasms: an immunohistochemieal study of 215 cases. Am J Surg Pathol, 2002,26( 11 ) : 1477-1483.
  • 6Choi YL, Kim HS, Ahn G. Immunoexpression of inhibin alpha subunit, inhibin/activin betaA subunit and CD99 in ovarian tumors. Arch Pathol Lab Med, 2000,124 (4) :563-569.
  • 7McCluggage WG, McKenna M, McBride HA. CD56 is a sensitive and diagnostically useful immunohistochemical marker of ovarian sex cord-stromal tumors. Int J Gynecol Pathol, 2007,26 ( 3 ) : 322- 327.
  • 8Zheng W,Senturk BZ, Parkash V. Inhibin immunohistochemical staining: a practical approach for the surgical pathologist in the diagnoses of ovarian sex cord-stromal tumors. Adv Anat Pathol, 2003,10( 1 ) :27-38.
  • 9Irving JA, McCluggage WG. Ovarian spindle cell lesions: a review with emphasis on recent developments and differential diagnosis. Adv Anat Pathol,2007,14 (5) :305-319.
  • 10Baranova A, Gowder S, Naouar S, et al. Expression profile of ovarian tumors: distinct signature of Sertoli-Leydig cell tumor. Int J Gynecol Cancer,2006, 16(6) :1963-1972.

共引文献10

同被引文献30

引证文献4

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部